People at risk of developing rheumatoid arthritis could benefit from taking an existing medication prescribed for established cases of the condition.
A clinical trial found the drug abatacept to be “effective in preventing the onset” of rheumatoid arthritis. Researchers said their findings could be “promising news” for the health service as it works to keep up with an ageing population.
Abatacept is currently prescribed to people who already have rheumatoid arthritis, but a team led by King’s College London set out to explore if it can prevent the disease in those deemed at risk.
Rheumatoid arthritis is a long-term condition that causes painful swelling and stiffness in the joints. It is estimated that 450,000 adults in the UK have been diagnosed with the disease. Try MEN Premium now for FREE...
Read more on manchestereveningnews.co.uk